Acute Myeloid Leukemia


U.S. FDA Approves Trisenox® Injection for First Line Treatment of Acute Promyelocytic Leukemia (01-31-2018)

CancerConnect News: the U.S. Food and Drug Administration (FDA) has approved the use of Trisenox® (arsenic trioxide) injection in combination with tretinoin for the treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL)... Continue Reading

FDA Approves Mylotarg for Treatment of Acute Myeloid Leukemia (09-5-2017)

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also approved Mylotarg for... Continue Reading

Venclexta® and Low-doses of Cytarabine Effective in Elderly with Acute Myeloid Leukemia (01-26-2017)

The treatment combination consisting of Venclexta® (venetoclax) plus low-doses of the chemotherapy agent cytarabine appears to be an effective and tolerable treatment regimen for elderly patients with acute myeloid leukemia (AML) who are not eligible... Continue Reading

Life’s Lessons Learned Early (03-20-2009)

By Diana Price When Pia Awal went to the emergency room in June 2002 after suffering from a fever that antibiotics couldn’t wipe out and bone pain that was getting increasingly worse, the last thing she expected to hear was a cancer diagnosis. And when... Continue Reading

Survival Rates Improving in Childhood Hematologic Cancers (09-29-2008)

Survival Rates Improving in Childhood Hematologic Cancers Five- and 10-year survival rates in childhood hematalogic cancers have significantly improved since 1990, according to the results of a study recently published in the Journal of the National Cancer... Continue Reading

Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia (08-12-2008)

Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia The injection of stem cells collected from umbilical cords into the pelvic bone of patients with leukemia appears promising; however, longer follow-up is necessary to determine... Continue Reading

Prophylactic Use of Specific Antibiotics Reduce the Risk of Some Infections in AML (07-28-2008)

Prophylactic Use of Specific Antibiotics Reduce the Risk of Some Infections in AML Specific antibiotics used during remission (no evidence of disease) following induction therapy reduce the risk of some types of infection and associated complications... Continue Reading